Cressey & Company, a private investment company focused on healthcare services and partnerships, has promoted Dan Vollman to Principal.
Dan joined Cressey & Company in 2021 and has been a vital part of expanding new investment opportunities, helping to drive portfolio company growth, and strengthening relationships throughout the healthcare industry. His contributions have played an essential role in helping the firm stay on track.
Health Technology Insights: MaaT Pharma, Clinigen Partner to Commercialize Xervyteg in Europe
Prior to his time at Cressey & Company, Dan worked in healthcare investing and finance. His promotion also speaks to his leadership abilities, as well as his relentless commitment to driving value in the firm’s portfolio of healthcare-oriented investments.
Health Technology Insights: JCR Pharmaceuticals Completes Enrollment for JR-141 Phase III Trial
Cressey & Company’s executives conveyed faith in Dan’s enhanced role and reflected on his capacity to empower founders and executives to create resilient, high-impact companies. The company continues to invest in firms that have a mission to enhance the delivery of care and foster innovation throughout the healthcare system.
The promotion underscores the company’s consistent commitment to fostering internal talent and enhancing its leadership team as it strives for future growth.
Health Technology Insights: Bradford Health Acquires 3 Addiction Centers in Texas
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
